Blood Glucose Levels in Children During Anesthesia
1 other identifier
observational
350
1 country
1
Brief Summary
This cross-sectional study aims to investigate blood glucose levels in children during general anesthesia and explore the incidence of hypoglycemia after anesthesia induction in relation to preoperative fasting. Blood glucose will be measured following anesthesia induction and prior to discontinuing the administration of the anesthetic agent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2025
CompletedFirst Submitted
Initial submission to the registry
March 31, 2025
CompletedFirst Posted
Study publicly available on registry
April 8, 2025
CompletedApril 11, 2025
April 1, 2025
1.4 years
March 31, 2025
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum blood glucose level
Blood glucose sampling and measured during general anesthesia
Immediately/within five minutes after anesthesia induction and prior to discontinuing the anesthesia administration.
Interventions
Blood glucose measurements during general anesthesia
Eligibility Criteria
Convenience sample of children undergoing elective intervention under general anesthesia at Landspítali, the University Hospital of Iceland.
You may qualify if:
- Children under 18 years of age who undergo intervention under general anesthesia. The parent or guardian understands and speaks Icelandic.
You may not qualify if:
- Coexisting disease or treatment that may affect fasting blood glucose level; Preoperative intravenous fluid administration; Beta-blockers; Insulin and corticosteroids, endocrine disorders, acute pain, and emergency interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Landspitali University Hospitallead
- University of Icelandcollaborator
Study Sites (1)
Anesthesia Department Landspitali UH
Reykjavik, 101, Iceland
Biospecimen
Capillary blood sample glucose
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thorunn S Eliasdottir, PhD
Landspitali, the University Hospital of Iceland and University of Iceland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Academic chair, Associate Professor
Study Record Dates
First Submitted
March 31, 2025
First Posted
April 8, 2025
Study Start
October 1, 2023
Primary Completion
March 3, 2025
Study Completion
March 3, 2025
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- May 2025 - December 2026